GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $427,000 | +59.3% | 9,801 | +59.3% | 0.13% | +152.9% |
| Q1 2022 | $268,000 | +14.0% | 6,151 | +15.3% | 0.05% | +18.6% |
| Q4 2021 | $235,000 | +16.9% | 5,335 | +11.0% | 0.04% | -49.4% |
| Q1 2019 | $201,000 | -13.7% | 4,806 | -16.1% | 0.08% | -35.6% |
| Q3 2017 | $233,000 | -5.7% | 5,730 | 0.0% | 0.13% | -10.8% |
| Q2 2017 | $247,000 | +22.9% | 5,730 | +9.6% | 0.15% | -1.3% |
| Q4 2016 | $201,000 | -11.1% | 5,230 | 0.0% | 0.15% | -15.7% |
| Q3 2016 | $226,000 | -18.1% | 5,230 | -23.5% | 0.18% | -24.9% |
| Q4 2015 | $276,000 | +3.4% | 6,841 | -1.4% | 0.24% | -3.3% |
| Q3 2015 | $267,000 | -19.3% | 6,941 | -12.6% | 0.24% | -12.8% |
| Q2 2015 | $331,000 | -9.6% | 7,941 | 0.0% | 0.28% | -0.4% |
| Q1 2015 | $366,000 | +28.4% | 7,941 | +19.2% | 0.28% | +18.0% |
| Q4 2014 | $285,000 | – | 6,661 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
| KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
| NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
| EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
| Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
| Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
| Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
| Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
| P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |